These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Reist CJ; Archer GE; Wikstrand CJ; Bigner DD; Zalutsky MR Cancer Res; 1997 Apr; 57(8):1510-5. PubMed ID: 9108453 [TBL] [Abstract][Full Text] [Related]
9. Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB). Wuest F; Köhler L; Berndt M; Pietzsch J Amino Acids; 2009 Feb; 36(2):283-95. PubMed ID: 18414978 [TBL] [Abstract][Full Text] [Related]
10. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN. Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531 [TBL] [Abstract][Full Text] [Related]
11. N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At. Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR Nucl Med Biol; 2003 May; 30(4):351-9. PubMed ID: 12767391 [TBL] [Abstract][Full Text] [Related]
12. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate. Vaidyanathan G; Affleck DJ; Zalutsky MR Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137 [TBL] [Abstract][Full Text] [Related]
13. Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR. Foulon CF; Welsh PC; Bigner DD; Zalutsky MR Nucl Med Biol; 2001 Oct; 28(7):769-77. PubMed ID: 11578897 [TBL] [Abstract][Full Text] [Related]
14. Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands. Hens M; Vaidyanathan G; Welsh P; Zalutsky MR Nucl Med Biol; 2009 Feb; 36(2):117-28. PubMed ID: 19217523 [TBL] [Abstract][Full Text] [Related]
15. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies. Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039 [TBL] [Abstract][Full Text] [Related]